Compare Newmont Corporation (NEM) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Newmont Corporation trades at $92.38 (market cap $95.23B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: Newmont Corporation pays a 1.17% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Newmont Corporation nearer its low. Which is the better fit depends on your goals.
| NEM | XBI | |
|---|---|---|
Market Cap | $95.23B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $131.95 | $164.28 |
52-Week Low | $59.86 | $85.16 |
Enterprise Value | $91.98B | — |
Dividend Yield | 1.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
